TSS
TMO icon

Two Sigma Securities’s Thermo Fisher Scientific TMO Stock Holding History

Two Sigma Securities’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-800
Closed -$416K – 2199
2024
Q4 		$416K Sell
800
-5,700
-88% -$3.13M 0.06% 457
2024
Q3 		$4.02M Buy
6,500
+3,700
+132% +$2.19M 0.07% 337
2024
Q2 		$1.55M Sell
2,800
-14,200
-84% -$8.13M 0.02% 845
2024
Q1 		$9.88M Sell
17,000
-12,000
-41% -$6.73M 0.1% 232
2023
Q4 		$15.4M Buy
29,000
+14,500
+100% +$7.02M 0.15% 143
2023
Q3 		$7.34M Buy
14,500
+7,600
+110% +$4.05M 0.08% 256
2023
Q2 		$3.6M Sell
6,900
-500
-7% -$270K 0.05% 390
2023
Q1 		$4.27M Sell
7,400
-900
-11% -$507K 0.09% 282
2022
Q4 		$4.57M Buy
8,300
+5,200
+168% +$2.76M 0.14% 167
2022
Q3 		$1.57M Sell
3,100
-300
-9% -$168K 0.05% 447
2022
Q2 		$1.85M Buy
3,400
+1,100
+48% +$605K 0.07% 330
2022
Q1 		$1.36M Buy
2,300
+1,100
+92% +$632K 0.05% 474
2021
Q4 		$801K Sell
1,200
-11,900
-91% -$7.43M 0.03% 337
2021
Q3 		$7.48M Buy
13,100
+12,000
+1,091% +$6.59M 0.22% 65
2021
Q2 		$555K Buy
+1,100
New +$519K 0.02% 615
2021
Q1 		– Sell
-5,200
Closed -$2.42M – 1715
2020
Q4 		$2.42M Sell
5,200
-100
-2% -$46.9K 0.06% 215
2020
Q3 		$2.34M Buy
5,300
+3,100
+141% +$1.28M 0.05% 181
2020
Q2 		$797K Sell
2,200
-1,800
-45% -$603K 0.02% 469
2020
Q1 		$1.13M Sell
4,000
-36,200
-90% -$11.4M 0.03% 365
2019
Q4 		$13.1M Buy
40,200
+15,600
+63% +$4.73M 0.09% 164
2019
Q3 		$7.17M Sell
24,600
-100
-0.4% -$28.6K 0.07% 230
2019
Q2 		$7.25M Buy
24,700
+5,700
+30% +$1.57M 0.08% 167
2019
Q1 		$5.2M Sell
19,000
-17,600
-48% -$4.38M 0.05% 168
2018
Q4 		$8.19M Buy
36,600
+4,400
+14% +$1.03M 0.1% 107
2018
Q3 		$7.86M Sell
32,200
-22,500
-41% -$5.18M 0.05% 255
2018
Q2 		$11.3M Sell
54,700
-4,900
-8% -$1.04M 0.06% 254
2018
Q1 		$12.3M Buy
59,600
+45,300
+317% +$9.51M 0.07% 238
2017
Q4 		$2.71M Buy
+14,300
New +$2.74M 0.07% 206

Other funds holding TMO

JSC
J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Two Sigma Securities's TMO Position: Q4 2025 in Review

Two Sigma Securities sold out of Thermo Fisher Scientific (TMO) in Q4 2025, closing a stake of 1,430 shares — an estimated $694K sold.

Two Sigma Securities first reported a position in TMO in Q3 2016 and held it in 24 quarters. The position peaked at $4.72M in Q2 2025. 2,699 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

  • Two Sigma Securities reported no remaining Thermo Fisher Scientific position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Securities sold 1,430 Thermo Fisher Scientific shares in Q4 2025, an estimated $694K.
  • Two Sigma Securities first reported a position in Thermo Fisher Scientific in Q3 2016 and held it in 24 quarters.
  • Two Sigma Securities's Thermo Fisher Scientific position peaked at $4.72M in Q2 2025.
  • 2,699 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on Two Sigma Securities's 13F filing for Q4 2025, filed 17 Feb 2026.